Management of Pediatric Cancer in the COVID-19 ERA
Children with cancer are immunocompromised and are at higher risk of
developing serious complications because of infection exposure. During
COVID-19 pandemic, many major challenges face pediatric oncologist
regarding the continuity of the anticancer therapy, hospital admission,
infection protection precautions and expected critical complication post
infection in pediatric cancer patients. This raises a question of how to
organize pediatric cancer care in the COVID-19 ERA? We propose some
critical recommendations focusing primarily on viral infection
prevention and control strategies, avoid significant myelosuppression
and decreasing the duration of hospitalization or the use of medical
resources